arrow
A

Ana I. Lalanne

Institut Curie
H指数:16
被引数:2,325

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial

基于病毒载体的个体化新抗原疫苗作为头颈部鳞状细胞癌切除术后辅助治疗:一项随机I期临床试验

2026-08-170
OAAI
CMV seropositivity associates with poor clinical outcome in triple negative breast cancer

CMV血清阳性与三阴性乳腺癌的不良临床结局相关联

2026-02-190
OAAI
Divergent local and systemic antitumor response in primary uveal melanomas
2024-04-021
OAAI
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
2023-09-016
PRE
Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer
2023-04-141
PRE
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer
2023-02-0340
OA
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes
2021-09-2413
OA
Splicing Patterns in SF3B1-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes
2021-04-0251
OA
Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naive CD8+T Cells in Type 1 Diabetic and Healthy Donors
2018-12-01160
OAAI
Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors
2018-02-09188
OAAI